Israel Acquisitions Corp logo

ISRL

ETFNASDAQ

Israel Acquisitions Corp

ISRL is an ETF, not a company. An exchange-traded fund holds a basket of assets and trades like a stock.

Israel Acquisitions Corp (ISRL) is an exchange-traded fund (ETF) listed on NASDAQ. There were no new wire items for ISRL in the last 30 days. The most recent was published Sep 1, 2026.

News · 26 weeks10%
2026-05-17: 02026-05-24: 02026-05-31: 02026-06-07: 02026-06-14: 02026-06-21: 02026-06-28: 02026-07-05: 02026-07-12: 02026-07-19: 02026-07-26: 02026-08-02: 02026-08-09: 02026-08-16: 02026-08-23: 02026-08-30: 12026-09-06: 02026-09-13: 02026-09-20: 02026-09-27: 02026-10-04: 02026-10-11: 02026-10-18: 02026-10-25: 02026-11-01: 02026-11-08: 0
2026-05-172026-11-08
Mix190d
  • Other1(100%)
Activity · 52 weeks54 active days
Tap a day to see what happenedEarningsInsiderAnalystFilings and news

Latest news

25 items

ISRL FAQ

6 questions
  • What is the latest news on ISRL?
    Quantisnow has not tracked any new filings, ratings or press releases for ISRL in the last 30 days. The most recent wire item was published on September 1, 2026.
  • Where does ISRL stock trade?
    Israel Acquisitions Corp (ISRL) is listed on NASDAQ.
  • What sector and industry is ISRL in?
    Israel Acquisitions Corp operates in the Finance sector, Blank Checks industry.
  • When did Israel Acquisitions Corp go public?
    Israel Acquisitions Corp (ISRL) completed its IPO in 2023.
  • What companies are similar to ISRL?
    Notable peers in the same industry include PRE (Prenetics Global Limited), OXSQ (Oxford Square Capital Corp.), INV (Innventure Inc.), ILLU (Illumination Acquisition Corp I), TACO (Berto Acquisition Corp.). Compare ISRL side-by-side with any of them on Quantisnow.
  • How can I track ISRL on Quantisnow?
    Quantisnow aggregates Israel Acquisitions Corp's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow ISRL to receive live email and push alerts on every new disclosure.